Compare Definium Therapeutics Inc. Common Shares (DFTX) vs VanEck Australian Floating Rate ETF (FLOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs VanEck Australian Floating Rate ETF — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.55 (market cap $4.59B), while VanEck Australian Floating Rate ETF trades at $50.96 (market cap $11.24B). The key difference: VanEck Australian Floating Rate ETF is far larger — about 2.4× Definium Therapeutics Inc. Common Shares's market cap, and Definium Therapeutics Inc. Common Shares is more actively traded (2,103,937 versus 1,872,962). Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and VanEck Australian Floating Rate ETF for 21 Days on average.
| DFTX | FLOT | |
|---|---|---|
Market Cap | $4.59B | $11.24B |
Volume | 2,103,937 | 1,872,962 |
Sector | Health | Fixed Income |
52-Week High | $48.45 | $51.07 |
52-Week Low | $10.68 | $50.72 |
Typical Hold Time | 0 Days | 21 Days |
Enterprise Value | $3.55B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
FLOT trades at $50.91 with minimal daily movement (-0.02%). Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators remain neutral. Recent dividend distributions of $0.17-$0.18 highlight income generation. The ETF benefits from floating rate exposure amid Fed tightening cycles, though concentration risk in bank holdings (47% exposure) warrants attention.
Outlook remains tied to interest rate trajectory, with FLOT positioned to benefit from higher rates. Key risks include bank sector concentration and Fed policy shifts. The current technical weakness suggests cautious near-term momentum despite the floating rate advantage in rising rate environments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About VanEck Australian Floating Rate ETF
FLOT provides exposure to a diversified portfolio of Australian dollar-denominated floating rate notes. It tracks the Bloomberg AusBond Credit FRN 0+ Yr Index, focusing on high-quality, investment-grade bonds from top Australian banks and financial institutions.
Read more on FLOT →
